Search results for: 'manag fuels develop deceleration'

24 Jan 2023  |  North America  |  Market Research

US Healthcare Claims Management Growth Opportunities

Intelligent Tools to Automate Payer and Provider Functions Will Boost Efficiency and Deliver a Digital Customer Experience

Infographics

×

The healthcare claims management industry is evolving. Changes include a shifting reimbursement landscape (for virtual care, urgent care, telehealth, and at-home care); a transition to new, value-based care models (e.g., population-based reimbursement and partial and full capitation payment); and disruption from big tech companies, big-box retailer...

This research service will provide an overview of the US population health management (PHM) market. The study period is from 2021 to 2026. The report will provide a detailed analysis of the PHM market and applications, such as data & analysis, care management, and performance management. Discussions include industry challenges, drivers, and restrai...

17 Jan 2023  |  North America  |  Market Research

Global Cardiac Rhythm Management Devices, 2022

Innovation Culture Bridges Gaps in Care Pathways

Infographics

×

This study provides an overview of global cardiac rhythm management (CRM) devices, covering pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, and implantable cardiac monitors (ICMs). It offers a detailed analysis of market sizing, trends, competitive landscape, future market outlook by regio...

The population health management (PHM) market continues to benefit from provider participation in risk-based reimbursement models, including Medicare Advantage, the Medicare Shared Savings Program, and other value-based care arrangements. As organizations assume greater financial accountability, demand is increasing for platforms that can improve q...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

As the number of aging, technologically obsolete imaging systems at medical facilities heightens the need for replacement to new imaging equipment with advanced technology, hospitals and imaging centers (especially in developing economies) seek Managed Equipment Services models that provide a viable long-term equipment procurement strategy. Managed...

As the number of aging, technologically obsolete imaging systems at medical facilities increases the need to shift to new imaging equipment with advanced technology, hospitals and imaging centers especially in developing economies seek MES models that provide a viable long-term equipment procurement strategy. MES offers technical infrastructure sup...

Frost & Sullivan expects the global MedTech managed vendor services market to witness significant changes over the next few years, driven by the increasing technology adoption by managed equipment services (MES), multi-vendor services (MVS), and professional service providers. They will do so due to the transformations in healthcare facilities, the...

Non-alcoholic steatohepatitis (NASH) is a chronic liver condition whose prevalence across the globe continues to rise year on year. The liver disorder is considered very dangerous as its symptoms can be mistaken for other liver disorders and conditions. Moreover, the disease can quickly progress to result in liver failure for the patients. The incr...